{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:21:21Z","timestamp":1790785281971,"version":"4.1.0"},"reference-count":64,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007771","name":"Medical University of Silesia (Katowice, Poland)","doi-asserted-by":"publisher","award":["PCN-1-187\/N\/1\/I"],"award-info":[{"award-number":["PCN-1-187\/N\/1\/I"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Tachycardia is a common cardiovascular disease. Drugs blocking \u03b21-adrenergic receptors (ADRB1) are used in the therapy of arrhythmogenic heart diseases. Disease-related polymorphisms can be observed within the ADRB1 gene. The two most important are Ser49Gly and Arg389Gly, and they influence the treatment efficacy. The family of the cytochrome P450 system consists of the isoenzyme CYP2D6 (Debrisoquine 4-hydroxylase), which is involved in phase I metabolism of almost 25% of clinically important drugs, including antiarrhythmic drugs. A study was conducted to detect the ADRB1 and CYP2D6 gene polymorphisms. Materials and Methods: The material for the test was whole blood from 30 patients with ventricular and supraventricular tachycardia and 20 controls. The samples were obtained from the Department of Pediatric Cardiology. The first to be made was the extraction of DNA using a GeneMATRIX Quick Blood DNA Purification Kit from EURx. The selected ADRB1 and CYP2D6 gene polymorphisms were detected by high-resolution melting polymerase chain reaction (HRM-PCR) analysis. Results: Based on the analysis of melt profile data for each PCR product, the identification of polymorphisms was carried out. Heterozygotes and homozygotes were found in the examined alleles. Conclusions: The frequency of the Arg389Gly polymorphism differs statistically significantly between the control group and patients with supraventricular and ventricular arrhythmias, as well as between these two groups of patients. Moreover, the Arg389Gly polymorphism was statistically more prevalent in the group of girls with SVT arrhythmia compared to girls with VT. A few carriers of homozygous and heterozygous systems of the S49G polymorphism were detected among patients with arrhythmias, as well as control group. The percentage of individuals carrying the CYP2D6 4 allele as either homozygous or heterozygous was observed in the study and control groups. The high prevalence of the CYP2D6*4 allele carriers in both groups prompts the optimization of beta-1 blocker therapy.<\/jats:p>","DOI":"10.3390\/medicina59122057","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T12:12:13Z","timestamp":1700568733000},"page":"2057","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Associations between Selected ADRB1 and CYP2D6 Gene Polymorphisms in Children with Ventricular and Supraventricular Arrhythmias"],"prefix":"10.3390","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1181-2824","authenticated-orcid":false,"given":"Ewa","family":"Moric-Janiszewska","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jedno\u015bci 8B, 41-200 Sosnowiec, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Smolik","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jedno\u015bci 8B, 41-200 Sosnowiec, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Les\u0142aw","family":"Szyd\u0142owski","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Medyk\u00f3w 16, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5189-1171","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Kapral","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jedno\u015bci 8B, 41-200 Sosnowiec, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clpt.2006.03.004","article-title":"\u03921-Adrenergic Receptor Polymorphisms Influence the Response to Metoprolol Monotherapy in Patients with Essential Hypertension","volume":"80","author":"Liu","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/FJC.0000000000000119","article-title":"Association of Common Polymorphisms in \u03921-Adrenergic Receptor With Antihypertensive Response to Carvedilol","volume":"64","author":"Si","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.amjcard.2008.04.070","article-title":"Impact of Beta1-Adrenergic Receptor Polymorphisms on Susceptibility to Heart Failure, Arrhythmogenesis, Prognosis, and Response to Beta-Blocker Therapy","volume":"102","author":"Biolo","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/eurjhf\/hfs181","article-title":"Effect of Bucindolol on Heart Failure Outcomes and Heart Rate Response in Patients with Reduced Ejection Fraction Heart Failure and Atrial Fibrillation","volume":"15","author":"Kao","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1389200217666151105125425","article-title":"Impact of CYP2D6 Genetic Variation on the Response of the Cardiovascular Patient to Carvedilol and Metoprolol","volume":"17","author":"Lymperopoulos","year":"2015","journal-title":"Curr. Drug Metab."},{"key":"ref_6","first-page":"301","article-title":"Methylation of Adrenergic \u03921 Receptor Is a Potential Epigenetic Mechanism Controlling Antihypertensive Response to Metoprolol","volume":"48","author":"Jiang","year":"2011","journal-title":"Indian J. Biochem. Biophys."},{"key":"ref_7","unstructured":"Cacabelos, R. (2019). Pharmacoepigenetics, Elsevier."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jacc.2012.01.067","article-title":"Clinical Application of Cardiovascular Pharmacogenetics","volume":"60","author":"Voora","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/jhg.2015.78","article-title":"Cardiovascular Pharmacogenomics: Current Status and Future Directions","volume":"61","author":"Roden","year":"2016","journal-title":"J. Hum. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1124\/mol.63.6.1256","article-title":"The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints","volume":"63","author":"Fredriksson","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"ref_11","first-page":"121","article-title":"International Union of Pharmacology Nomenclature of Adrenoceptors","volume":"46","author":"Bylund","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/B978-0-12-391861-1.00006-X","article-title":"Structure of \u03b2-Adrenergic Receptors","volume":"Volume 520","author":"Brueckner","year":"2013","journal-title":"Methods in Enzymology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3389\/fphar.2018.00904","article-title":"New Insights in Cardiac \u03b2-Adrenergic Signaling During Heart Failure and Aging","volume":"9","author":"Eguchi","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1172\/JCI118823","article-title":"Functional Beta3-Adrenoceptor in the Human Heart","volume":"98","author":"Gauthier","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/B978-0-12-384921-2.00009-4","article-title":"\u03b2-Adrenergic Receptor Subtype Signaling in the Heart: From Bench to the Bedside","volume":"Volume 67","author":"Zhu","year":"2011","journal-title":"Current Topics in Membranes"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.RES.59.3.297","article-title":"Beta 1- and Beta 2-Adrenergic-Receptor Subpopulations in Nonfailing and Failing Human Ventricular Myocardium: Coupling of Both Receptor Subtypes to Muscle Contraction and Selective Beta 1-Receptor down-Regulation in Heart Failure","volume":"59","author":"Bristow","year":"1986","journal-title":"Circ. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.RES.0000102042.83024.CA","article-title":"What Is the Role of \u03b2-Adrenergic Signaling in Heart Failure?","volume":"93","author":"Lohse","year":"2003","journal-title":"Circ. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/01.CIR.103.12.1649","article-title":"Upregulation of \u03b23-Adrenoceptors and Altered Contractile Response to Inotropic Amines in Human Failing Myocardium","volume":"103","author":"Moniotte","year":"2001","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/CIRCRESAHA.117.310520","article-title":"Adrenergic Receptors in Individual Ventricular Myocytes: The Beta-1 and Alpha-1B Are in All Cells, the Alpha-1A Is in a Subpopulation, and the Beta-2 and Beta-3 Are Mostly Absent","volume":"120","author":"Myagmar","year":"2017","journal-title":"Circ. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/415206a","article-title":"Seven-Transmembrane-Spanning Receptors and Heart Function","volume":"415","author":"Rockman","year":"2002","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3389\/fgene.2018.00560","article-title":"Beta 1, Beta 2 and Beta 3 Adrenergic Receptor Gene Polymorphisms in a Southeastern European Population","volume":"9","author":"Katsarou","year":"2018","journal-title":"Front. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1124\/pr.113.008219","article-title":"Polymorphic Variants of Adrenoceptors: Pharmacology, Physiology, and Role in Disease","volume":"66","author":"Ahles","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10741-008-9094-x","article-title":"\u03b2-Blocker Pharmacogenetics in Heart Failure","volume":"15","author":"Shin","year":"2010","journal-title":"Heart Fail. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"FSO895","DOI":"10.2144\/fsoa-2023-0113","article-title":"\u03921-Adrenergic Receptor Polymorphisms: A Possible Genetic Predictor of Bisoprolol Response in Acute Coronary Syndrome","volume":"9","author":"Fayed","year":"2023","journal-title":"Future Sci. OA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/03602530903118729","article-title":"New Insights into the Structural Characteristics and Functional Relevance of the Human Cytochrome P450 2D6 Enzyme","volume":"41","author":"Wang","year":"2009","journal-title":"Drug Metab. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejphar.2013.12.025","article-title":"The Endogenous Substrates of Brain CYP2D","volume":"724","author":"Wang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2133\/dmpk.DMPK-11-RV-121","article-title":"Pharmacogenomics of CYP2D6: Molecular Genetics, Interethnic Differences and Clinical Importance","volume":"27","author":"Teh","year":"2012","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2217\/pgs.12.27","article-title":"Use of CYP2D6 Genotyping in Practice: Tamoxifen Dose Adjustment","volume":"13","author":"Walko","year":"2012","journal-title":"Pharmacogenomics"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Leit\u00e3o, L.P.C., Souza, T.P., Rodrigues, J.C.G., Fernandes, M.R., Santos, S., and Santos, N.P.C. (2020). The Metabolization Profile of the CYP2D6 Gene in Amerindian Populations: A Review. Genes, 11.","DOI":"10.3390\/genes11030262"},{"key":"ref_30","first-page":"e02101284","article-title":"Interacciones farmacocin\u00e9ticas de la azitromicina e implicaci\u00f3n cl\u00ednica","volume":"50","year":"2021","journal-title":"Rev. Cuba. Med. Mil."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 Enzymes in Drug Metabolism: Regulation of Gene Expression, Enzyme Activities, and Impact of Genetic Variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/FPC.0000000000000363","article-title":"CYP2D6 Haplotypes with Enhancer Single-Nucleotide Polymorphism Rs5758550 and Rs16947 (*2 Allele): Implications for CYP2D6 Genotyping Panels","volume":"29","author":"Ray","year":"2019","journal-title":"Pharmacogenetics Genom."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Jessurun, N.T., Wijnen, P.A., Bast, A., van Puijenbroek, E.P., Bekers, O., and Drent, M. (2020). Tamsulosin Associated with Interstitial Lung Damage in CYP2D6 Variant Alleles Carriers. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082770"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1007\/s11064-017-2384-8","article-title":"Cytochrome P450 2D6 and Parkinson\u2019s Disease: Polymorphism, Metabolic Role, Risk and Protection","volume":"42","author":"Mishra","year":"2017","journal-title":"Neurochem. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00210-003-0832-2","article-title":"Cytochrome P450 2D6: Overview and Update on Pharmacology, Genetics, Biochemistry","volume":"369","author":"Zanger","year":"2004","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/omi.2016.0166","article-title":"Lessons from Cuba for Global Precision Medicine: CYP2D6 Genotype Is Not a Robust Predictor of CYP2D6 Ultrarapid Metabolism","volume":"21","author":"Dorado","year":"2017","journal-title":"OMICS J. Integr. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e922","DOI":"10.1002\/mgg3.922","article-title":"Results and Challenges of Cytochrome P450 2D6 (CYP2D6) Testing in an Ethnically Diverse South Florida Population","volume":"7","author":"Salyakina","year":"2019","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Lu, Y., Mo, C., Zeng, Z., Chen, S., Xie, Y., Peng, Q., He, Y., Deng, Y., Wang, J., and Xie, L. (2013). CYP2D6*4 Allele Polymorphism Increases the Risk of Parkinson\u2019s Disease: Evidence from Meta-Analysis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0084413"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/omi.2017.0101","article-title":"CYP450 Genotype\/Phenotype Concordance in Mexican Amerindian Indigenous Populations\u2013Where to from Here for Global Precision Medicine?","volume":"21","author":"Ramos","year":"2017","journal-title":"OMICS J. Integr. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4067\/S0034-98872017000400009","article-title":"Farmacogen\u00f3mica Como Herramienta Fundamental Para La Medicina Personalizada: Aplicaciones En La Pr\u00e1ctica Cl\u00ednica","volume":"145","author":"Roco","year":"2017","journal-title":"Rev. M\u00e9d. Chile"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3897\/pharmacia.68.e75165","article-title":"Frequency of CYP2D6*3 and *4 and Metabolizer Phenotypes in Three Mestizo Peruvian Populations","volume":"68","author":"Alvarado","year":"2021","journal-title":"Pharmacia"},{"key":"ref_42","first-page":"293","article-title":"High Resolution Melting as a Rapid, Reliable, Accurate and Cost-Effective Emerging Tool for Genotyping Pathogenic Bacteria and Enhancing Molecular Epidemiological Surveillance: A Comprehensive Review of the Literature","volume":"29","author":"Tamburro","year":"2017","journal-title":"Ann. Ig."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/cns.13443","article-title":"DNA Methylation Analysis with Methylation-Sensitive High-Resolution Melting (MS-HRM) Reveals Gene Panel for Glioma Characteristics","volume":"26","author":"Dybska","year":"2020","journal-title":"CNS Neurosci. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0735-1097(02)02137-X","article-title":"Conservation of the Cardiostimulant Effects of (\u2212)-Norepinephrine across Ser49Gly and Gly389Arg Beta1-Adrenergic Receptor Polymorphisms in Human Right Atrium in Vitro","volume":"40","author":"Molenaar","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1592\/phco.27.6.874","article-title":"Pharmacogenetics of \u03b2-Blockers","volume":"27","author":"Shin","year":"2007","journal-title":"Pharmacotherapy"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1475-2840-9-42","article-title":"Association of the Beta-1 Adrenergic Receptor Carboxyl Terminal Variants with Left Ventricular Hypertrophy among Diabetic and Non-Diabetic Survivors of Acute Myocardial Infarction","volume":"9","author":"Hakalahti","year":"2010","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Liu, W.-N., Fu, K.-L., Gao, H.-Y., Shang, Y.-Y., Wang, Z.-H., Jiang, G.-H., Zhang, Y., Zhang, W., and Zhong, M. (2012). \u03921 Adrenergic Receptor Polymorphisms and Heart Failure: A Meta-Analysis on Susceptibility, Response to \u03b2-Blocker Therapy and Prognosis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037659"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/FJC.0b013e31818d3878","article-title":"Genetic Polymorphisms of \u03921 Adrenergic Receptor and Their Influence on the Cardiovascular Responses to Metoprolol in a South Indian Population","volume":"52","author":"Ramu","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2478\/s11535-012-0078-4","article-title":"Ser49Gly and Arg389Gly Polymorphisms of the ADRB1 Gene and Endurance Performance","volume":"7","author":"Sawczuk","year":"2012","journal-title":"Open Life Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"616","DOI":"10.36660\/abc.20190187","article-title":"O Polimorfismo Gen\u00e9tico Do Receptor Beta-Adren\u00e9rgico Tipo 1 Ser49Gly \u00e9 Preditor de Morte Em Pacientes Brasileiros Com Insufici\u00eancia Card\u00edaca","volume":"114","author":"Albuquerque","year":"2020","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3892\/mmr.2015.3536","article-title":"Ser49Gly Polymorphism in the \u03b2-Adrenergic Receptor 1 Gene in a Population Sample from Rio de Janeiro State, Brazil, Stratified by Self-Identified Skin Color and Genetic Ancestry","volume":"12","author":"Santos","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/clpt.2012.18","article-title":"Impact of the \u03921-Adrenoceptor Arg389Gly Polymorphism on Heart-Rate Responses to Bisoprolol and Carvedilol in Heart-Failure Patients","volume":"92","author":"Rau","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Gu, R., Shen, Y., Liu, J., Qiao, S., Wang, L., and Xu, B. (2018). Association of Arg389Gly \u03921-Adrenergic Receptor Polymorphism with Effective Dose of \u03b2 Blocker in Congestive Heart Failure among Chinese Han Population. Genetics. bioRxiv.","DOI":"10.1101\/272013"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5604\/18967892.1196025","article-title":"R\u00f3\u017cnice w Wyst\u0119powaniu Poszczeg\u00f3lnych Zaburze\u0144 Rytmu Serca w Zale\u017cno\u015bci Od P\u0142ci i St\u0119\u017cenia Hormon\u00f3w P\u0142ciowych","volume":"1","author":"Topolska","year":"2016","journal-title":"Good Rythm."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e12978","DOI":"10.1111\/apha.12978","article-title":"Molecular Pathways of Oestrogen Receptors and \u03b2-Adrenergic Receptors in Cardiac Cells: Recognition of Their Similarities, Interactions and Therapeutic Value","volume":"222","author":"Machuki","year":"2018","journal-title":"Acta Physiol."},{"key":"ref_56","first-page":"265","article-title":"Gender and Cardiac Arrhythmias","volume":"28","author":"Villareal","year":"2001","journal-title":"Tex. Heart Inst. J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCRESAHA.121.319893","article-title":"Arrhythmias in Female Patients: Incidence, Presentation and Management","volume":"130","author":"Zeitler","year":"2022","journal-title":"Circ. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.tpj.6500285","article-title":"Genetic Polymorphisms of Cytochrome P450 2D6 (CYP2D6): Clinical Consequences, Evolutionary Aspects and Functional Diversity","volume":"5","year":"2005","journal-title":"Pharmacogenomics J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1517\/14622416.3.2.229","article-title":"CYP2D6 Allele Frequency in European Caucasians, Asians, Africans and Their Descendants","volume":"3","author":"Bradford","year":"2002","journal-title":"Pharmacogenomics"},{"key":"ref_60","first-page":"284","article-title":"Cytochrome P450 2D6 Variants in a Caucasian Population: Allele Frequencies and Phenotypic Consequences","volume":"60","author":"Sachse","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s11095-017-2104-8","article-title":"CYP2D6 Genetic Variation and Beta-Blocker Maintenance Dose in Patients with Heart Failure","volume":"34","author":"Luzum","year":"2017","journal-title":"Pharm. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/0300060514563151","article-title":"Associations between ADRB1 and CYP2D6 Gene Polymorphisms and the Response to \u03b2-Blocker Therapy in Hypertension","volume":"43","author":"Wu","year":"2015","journal-title":"J. Int. Med. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0009-9236(03)00224-8","article-title":"Gly389Arg Polymorphism of \u03921-Adrenergic Receptor Is Associated with the Cardiovascular Response to Metoprolol","volume":"74","author":"Liu","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Sethi, Y., Patel, N., Kaka, N., Kaiwan, O., Kar, J., Moinuddin, A., Goel, A., Chopra, H., and Cavalu, S. (2023). Precision Medicine and the Future of Cardiovascular Diseases: A Clinically Oriented Comprehensive Review. J. Clin. Med., 12.","DOI":"10.3390\/jcm12051799"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/12\/2057\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:26:33Z","timestamp":1760131593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/12\/2057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,21]]},"references-count":64,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["medicina59122057"],"URL":"https:\/\/doi.org\/10.3390\/medicina59122057","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,21]]}}}